Stevanato Group S.p.A (STVN) Free Cash Flow Growth (1y) (2021 - 2026)
Stevanato Group S.p.A (STVN) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 69.33% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -31.57% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -28.80% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -20.60% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 594.25% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -20.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 144.07% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 432.60% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 5.85% |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | -10.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.34% |
| Mar 31, 2026 | -7.31% |
| Dec 31, 2025 | 50.78% |
| Sep 30, 2025 | 58.77% |
| Jun 30, 2025 | 18.39% |
| Mar 31, 2025 | -4.25% |
| Dec 31, 2024 | 42.73% |
| Sep 30, 2024 | -61.58% |
| Jun 30, 2024 | -22.80% |
| Mar 31, 2024 | 5.68% |
| Dec 31, 2023 | -23.80% |
| Sep 30, 2023 | 386.14% |
| Jun 30, 2023 | 2.40% |
| Mar 31, 2023 | 172.12% |
| Dec 31, 2022 | 24.10% |
| Sep 30, 2022 | -30.78% |
| Jun 30, 2022 | 34.76% |
| Mar 31, 2022 | 95.22% |
| Dec 31, 2021 | -1.91% |
| Sep 30, 2021 | -34.35% |